Author

S. Kitamura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cancer Biology· 2 Biophysics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 4 Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:gene regulatory network inference· 2 Assay:proteomics· 2 Approach:statistical model· 2 Approach:comparative / phylogenetic analysis· 1

Frequent Co-Authors

D. W. Wolan· 4 shared B. D. Hammock· 2 shared C. Morisseau· 2 shared S. Sidoli· 2 shared A. Bergano· 1 shared A. Bettaieb· 1 shared A. Bustion· 1 shared A. K. Chatterjee· 1 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersBiochemistry

D. W. Wolan

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

In vivo-Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability

K. Nakane, C. Morisseau, P. D. Dowker-Key, G. Benitez, J. T. Aguilan, E. Nagai, S. Sidoli, B. D. Hammock, A. Bettaieb, K. Shinoda, S. Kitamura

This paper develops next-generation sEH-targeting PROTACs with improved potency and stability, showing effective degradation in mouse tissues.

bioRxiv · Jul 23, 2024Biochemistry

PROTAC-mediated selective degradation of cytosolic soluble epoxide hydrolase enhances ER-stress reduction

Y. Wang, C. Morisseau, A. Takamura, D. Wan, D. Li, S. Sidoli, J. Yang, D. W. Wolan, B. D. Hammock, S. Kitamura

This paper develops first-in-class PROTACs that selectively degrade cytosolic sEH, reducing ER stress more effectively than sEH inhibitors.

bioRxiv · Jan 20, 2022 · PreprintBiochemistry

Chemical inhibition of ENL/AF9 YEATS domains in acute leukemia

L. Garnar-Wortzel, T. R. Bishop, S. Kitamura, N. Milosevich, J. N. Asiaban, X. Zhang, Q. Zheng, E. Chen, A. R. Ramos, C. J. Ackerman, E. N. Hampton, A. K. Chatterjee, T. S. Young, M. V. Hull, K. B. Sharpless, , M. A. Erb

This study identifies a potent inhibitor of the ENL/AF9 YEATS domain and demonstrates its selective suppression of ENL-dependent leukemia genes.

bioRxiv · Dec 1, 2020Cancer Biology

An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.

Y. Yao, R. U. Kadam, C.-C. D. Lee, J. L. Woehl, N. C. Wu, X. Zhu, S. Kitamura, I. A. Wilson, D. W. Wolan

This paper identifies a small-molecule inhibitor of influenza A HA stem fusion using a fluorescence polarization screen and validates its antiviral activity against multiple H1N1 and H5N1 strains.

bioRxiv · Apr 2, 2020Biophysics

Transcriptome stability profiling identifies novel and functional MIRNA targets in melanoma cells

P. Joshi, T. Seki, S. Kitamura, A. Bergano, B. Lee, R. J. Perera

The paper uses RNA stability profiling to identify novel miR-211 targets in melanoma cells and validates their functional role in cell invasion and colony formation.

bioRxiv · Jun 1, 2019Cancer Biology

The Genetic Basis for the Cooperative Bioactivation of Plant Lignans by a Human Gut Bacterial Consortium

E. N. Bess, J. E. Bisanz, P. Spanogiannopoulos, Q. Y. Ang, A. Bustion, S. Kitamura, D. L. Alba, D. W. Wolan, S. K. Koliwad, P. J. Turnbaugh

The paper identifies the genetic basis for the cooperative bioactivation of plant lignans by a human gut bacterial consortium, revealing a complete metabolic pathway in most human gut microbiomes.

bioRxiv · Jul 16, 2018 · PreprintMicrobiology